CELYAD ONCOLOGY
LIVE

Serial Number

79298417

Owner

Celyad Oncology, Soci?t? anonyme

Attorney

Todd A. Denys

Filing Date

Oct 15, 2020

Add to watchlist:

No watchlists yet
View on USPTO

CELYAD ONCOLOGY Trademark

Serial Number: 79298417 • Registration: 6624226

CELYAD ONCOLOGY is a trademark filed by Celyad Oncology, Soci?t? anonyme on October 15, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Celyad Oncology, Soci?t? anonyme (6 trademarks)

Rue Edouard Belin 2

Entity Type: 99

Trademark Details

Filing Date

October 15, 2020

Registration Date

January 25, 2022

Published for Opposition

November 9, 2021

Goods & Services

Cellular pharmaceutical preparations for use in oncology and cardio-vascular diseases; implants comprised of living tissues, for pharmaceutical use; pharmaceutical products, namely, products for the treatment of tumors and cardio-vascular diseases; living tissue in the nature of chimeric antigen receptor (CAR-T) cells for medical use; compositions comprised of white blood cells, specifically T-cells and NK-cells, for pharmaceutical use; viral vectors in the nature of biological cultures for medical use; plasmids in the nature of DNA molecules for medical use

Bioreactors for medical analysis; apparatus for culture, proliferation and modification of human cells for medical purposes; apparatus for cell therapy; catheters; surgical and medical instruments for use in the diagnosis and treatment of oncology and cardio-vascular diseases; medical implants consisting of artificial materials

Scientific and technological services, namely, research, analysis and testing in the field of oncology and cardio-vascular diseases; scientific research services in the field of cell therapy, oncology, immuno-oncology and in the field of medical and surgical instruments

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Nov 21, 2025 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Mar 13, 2025 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 25, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 1, 2022 FICS
FINAL DISPOSITION PROCESSED
Jul 1, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 25, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Jan 25, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 9, 2021 NPUB
PUBLISHED FOR OPPOSITION
Nov 9, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 20, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 1, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 1, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 1, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 1, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 1, 2021 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 22, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 21, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 21, 2021 TROA
REFUSAL PROCESSED BY IB
Apr 13, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 24, 2021 RFCS
REFUSAL PROCESSED BY MPU
Mar 24, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 20, 2021 RFCR
NON-FINAL ACTION WRITTEN
Mar 19, 2021 CNRT
ASSIGNED TO EXAMINER
Mar 16, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 4, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 30, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 26, 2020 REPR